| Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic … BD Cheson, JM Bennett, KJ Kopecky, T Büchner, CL Willman, EH Estey, ... Journal of clinical oncology 21 (24), 4642-4649, 2003 | 3018 | 2003 |
| Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study ML Slovak, KJ Kopecky, PA Cassileth, DH Harrington, KS Theil, ... Blood, The Journal of the American Society of Hematology 96 (13), 4075-4083, 2000 | 2079 | 2000 |
| All-trans-retinoic acid in acute promyelocytic leukemia MS Tallman, JW Andersen, CA Schiffer, FR Appelbaum, JH Feusner, ... New England Journal of Medicine 337 (15), 1021-1028, 1997 | 1680* | 1997 |
| Age and acute myeloid leukemia FR Appelbaum, H Gundacker, DR Head, ML Slovak, CL Willman, ... Blood 107 (9), 3481-3485, 2006 | 1652 | 2006 |
| Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia CG Mullighan, X Su, J Zhang, I Radtke, LAA Phillips, CB Miller, J Ma, ... New England Journal of Medicine 360 (5), 470-480, 2009 | 1651 | 2009 |
| Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia KG Roberts, Y Li, D Payne-Turner, RC Harvey, YL Yang, D Pei, ... New England journal of medicine 371 (11), 1005-1015, 2014 | 1475 | 2014 |
| Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia WJ Song, MG Sullivan, RD Legare, S Hutchings, X Tan, D Kufrin, ... Nature genetics 23 (2), 166-175, 1999 | 1250 | 1999 |
| The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers CE Ashley, EC Carnes, GK Phillips, D Padilla, PN Durfee, PA Brown, ... Nature materials 10 (5), 389-397, 2011 | 1179 | 2011 |
| Langerhans'-cell histiocytosis (histiocytosis X)--a clonal proliferative disease CL Willman, L Busque, BB Griffith, BE Favara, KL McClain, MH Duncan, ... New England Journal of Medicine 331 (3), 154-160, 1994 | 1139 | 1994 |
| Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to … CP Leith, KJ Kopecky, J Godwin, T McConnell, ML Slovak, IM Chen, ... Blood, The Journal of the American Society of Hematology 89 (9), 3323-3329, 1997 | 1135 | 1997 |
| Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. KE Noonan, C Beck, TA Holzmayer, JE Chin, JS Wunder, IL Andrulis, ... Proceedings of the National Academy of Sciences 87 (18), 7160-7164, 1990 | 1067 | 1990 |
| Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study MJ Borowitz, M Devidas, SP Hunger, WP Bowman, AJ Carroll, WL Carroll, ... Blood, The Journal of the American Society of Hematology 111 (12), 5477-5485, 2008 | 973 | 2008 |
| Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia KG Roberts, RD Morin, J Zhang, M Hirst, Y Zhao, X Su, SC Chen, ... Cancer cell 22 (2), 153-166, 2012 | 836 | 2012 |
| The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia Y Liu, J Easton, Y Shao, J Maciaszek, Z Wang, MR Wilkinson, ... Nature genetics 49 (8), 1211-1218, 2017 | 801 | 2017 |
| Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia. A Southwest Oncology … CP Leith, KJ Kopecky, IM Chen, L Eijdems, ML Slovak, TS McConnell, ... Blood, The Journal of the American Society of Hematology 94 (3), 1086-1099, 1999 | 794 | 1999 |
| Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission PA Cassileth, DP Harrington, FR Appelbaum, HM Lazarus, JM Rowe, ... New England Journal of Medicine 339 (23), 1649-1656, 1998 | 791 | 1998 |
| JAK mutations in high-risk childhood acute lymphoblastic leukemia CG Mullighan, J Zhang, RC Harvey, JR Collins-Underwood, ... Proceedings of the National Academy of Sciences 106 (23), 9414-9418, 2009 | 744 | 2009 |
| Rearrangement of CRLF2 in B-progenitor– and Down syndrome–associated acute lymphoblastic leukemia CG Mullighan, JR Collins-Underwood, LAA Phillips, MG Loudin, W Liu, ... Nature genetics 41 (11), 1243-1246, 2009 | 725 | 2009 |
| Gene expression changes associated with progression and response in chronic myeloid leukemia JP Radich, H Dai, M Mao, V Oehler, J Schelter, B Druker, C Sawyers, ... Proceedings of the National Academy of Sciences 103 (8), 2794-2799, 2006 | 696 | 2006 |
| A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia SH Petersdorf, KJ Kopecky, M Slovak, C Willman, T Nevill, J Brandwein, ... Blood, The Journal of the American Society of Hematology 121 (24), 4854-4860, 2013 | 687 | 2013 |
Charles MullighanSt Jude Children's Research HospitalVerified email at stjude.org
